Shentracon Chemicals board to consider share split on Jul 28
Shentracon Chemicals Limited will hold a board meeting on July 28, 2026, to consider the sub-division of equity shares. The proposal requires shareholder and regulatory approvals under the Companies Act, 2013. The trading window for designated persons is closed until 48 hours after the meeting.

*this image is generated using AI for illustrative purposes only.
Shentracon Chemicals has scheduled a board meeting on July 28, 2026, to consider the sub-division of its existing equity shares, a move aimed at altering the company's capital structure. The proposal, subject to the approval of shareholders and regulatory authorities, will be evaluated under Section 61(1)(d) of the Companies Act, 2013.
The board's decision will determine the specific ratio and manner of the share split. The company stated that the alteration of capital is pursuant to applicable provisions and requires member approval before implementation.
In conjunction with the meeting announcement, Shentracon Chemicals has closed its trading window for all designated persons and their immediate relatives. The closure, effective from the date of the intimation, will remain in force until 48 hours after the conclusion of the board meeting, in line with the Company's Code of Conduct for Prevention of Insider Trading.
Key Meeting Details
| Detail | Information |
|---|---|
| Meeting Date | July 28, 2026 |
| Agenda | Sub-division/split of equity shares |
| Regulatory Basis | Regulation 29 of SEBI (LODR) Regulations, 2015 |
| Legal Basis | Section 61(1)(d) of the Companies Act, 2013 |
| Trading Window Closure | From July 23, 2026, till 48 hours post-meeting |
Historical Stock Returns for Shentracon Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.95% | +8.16% | +21.62% | +163.17% | +631.83% | +631.83% |
What specific split ratio is the board likely to propose, and how will it impact liquidity?
How will shareholders react to the split, and what level of approval is expected?
What are the potential regulatory hurdles, and how might they delay implementation?


































